Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

Retinoblastoma Tumor Suppressor Protein (RB)

  • Razvan T. Radulescu
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_101891

Synonyms

Historical Background

Isoforms of the retinoblastoma tumor suppressor protein (RB) have meanwhile been identified in many different species. As far as human RB is concerned, its gene has been found on chromosome 13 in 1983 (Cavenee et al. 1983). Subsequently, the sequences of the human RB gene and its encoded RB protein (encompassing 928 amino acids) have been communicated in 1986 (Friend et al. 1986) and, respectively, 1987 (Lee et al. 1987a). In the following 2 years, two important functional aspects of RB have been unveiled: its cell cycle-dependent phosphorylation (Chen et al. 1989; deCaprio et al. 1989) and its physical interaction with viral oncoproteins such as the E7 protein of the human papillomavirus (HPV) type 16 (Dyson et al. 1989). Within this same period, it was also discovered that the introduction of the intact RB gene into various tumor cells, e.g., human prostate carcinoma cells...

This is a preview of subscription content, log in to check access.

References

  1. Antelman D, Machemer T, Huyghe BG, Shepard HM, Maneval D, Johnson DE. Inhibition of tumor cell proliferation in vitro and in vivo by exogenous p110RB, the retinoblastoma tumor suppressor protein. Oncogene. 1995;10:697–704.PubMedPubMedCentralGoogle Scholar
  2. Bishop JM. How to win the Nobel prize – an unexpected life in science. Cambridge: Harvard University Press; 2003. p. 229.Google Scholar
  3. Bookstein R, Shew JY, Chen PL, Scully P, Lee WH. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science. 1990;247:712–5.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Brugarolas J, Moberg K, Boyd SD, Taya Y, Jacks T, Lees JA. Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation. Proc Natl Acad Sci U S A. 1999;96:1002–7.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature. 1983;305:779–84.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Chen PL, Scully P, Shew JY, Wang JY, Lee WH. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell. 1989;58:1193–8.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Choi YH, Kang HS, Yoo MA. Suppression of human prostate cancer cell growth by beta-lapachone via down-regulation of pRB phosphorylation and induction of Cdk inhibitor p21(WAF1/CIP1). J Biochem Mol Biol. 2003;36:223–9.PubMedPubMedCentralGoogle Scholar
  8. Costello LC, Franklin RB. Cytotoxic/tumor suppressor role of zinc for the treatment of cancer: an enigma and an opportunity. Expert Rev Anticancer Ther. 2012;12:121–8.PubMedPubMedCentralCrossRefGoogle Scholar
  9. DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang CM, Livingston DM. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell. 1989;58:1085–95.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Dyson N, Howley PM, Münger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989;243:934–7.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Fong LY, Nguyen VT, Farber JL, Huebner K, Magee PN. Early deregulation of the p16ink4a-cyclin D1/cyclin-dependent kinase 4-retinoblastoma pathway in cell proliferation-driven esophageal tumorigenesis in zinc-deficient rats. Cancer Res. 2000;60:4589–95.PubMedPubMedCentralGoogle Scholar
  12. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986;323:643–6.PubMedPubMedCentralCrossRefGoogle Scholar
  13. Harrington EA, Bruce JL, Harlow E, Dyson N. pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc Natl Acad Sci U S A. 1998;95:11945–50.PubMedPubMedCentralCrossRefGoogle Scholar
  14. Hernando E, Nahlé Z, Juan G, Diaz-Rodriguez E, Alaminos M, Hemann M, Michel L, Mittal V, Gerald W, Benezra R, Lowe SW, Cordon-Cardo C. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature. 2004;430:797–802.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Kaye FJ. RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer. Oncogene. 2002;21:6908–14.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Kuo HC, Kuo WH, Lee YJ, Lin WL, Chou FP, Tseng TH. Inhibitory effect of caffeic acid phenethyl ester on the growth of C6 glioma cells in vitro and in vivo. Cancer Lett. 2006;234:199–208.PubMedPubMedCentralCrossRefGoogle Scholar
  17. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science. 1987a;235:1394–9.PubMedPubMedCentralCrossRefGoogle Scholar
  18. Lee WH, Shew JY, Hong FD, Sery TW, Donoso LA, Young LJ, Bookstein R, Lee EY. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature. 1987b;329:642–5.PubMedPubMedCentralCrossRefGoogle Scholar
  19. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature. 1992;359:288–94.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Lee EY, Hu N, Yuan SS, Cox LA, Bradley A, Lee WH, Herrup K. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev. 1994a;8:2008–21.PubMedPubMedCentralCrossRefGoogle Scholar
  21. Lee WH, Xu Y, Hong F, Durfee T, Mancini MA, Ueng YC, Chen PL, Riley D. The corral hypothesis: a novel regulatory mode for retinoblastoma protein function. Cold Spring Harb Symp Quant Biol. 1994b;59:97–107.PubMedPubMedCentralCrossRefGoogle Scholar
  22. Michaud-Levesque J, Bousquet-Gagnon N, Béliveau R. Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration. Exp Cell Res. 2012;318:925–35.PubMedPubMedCentralCrossRefGoogle Scholar
  23. Oh M, Choi YH, Choi S, Chung H, Kim K, Kim SI, Kim DK, Kim ND. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol. 1999;14:869–75.PubMedPubMedCentralGoogle Scholar
  24. Osuga H, Osuga S, Wang F, Fetni R, Hogan MJ, Slack RS, Hakim AM, Ikeda JE, Park DS. Cyclin-dependent kinases as a therapeutic target for stroke. Proc Natl Acad Sci U S A. 2000;97:10254–9.PubMedPubMedCentralCrossRefGoogle Scholar
  25. Park YJ, Wen J, Bang S, Park SW, Song SY. [6]-Gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cells. Yonsei Med J. 2006;47:688–97.PubMedPubMedCentralCrossRefGoogle Scholar
  26. Radulescu RT. Planet RB: a personal contribution to a proteomic map of human retinoblastoma protein. 2007;arXiv:0706.1996.Google Scholar
  27. Radulescu RT. Going beyond the genetic view of cancer. Proc Natl Acad Sci U S A. 2008;105:E12.PubMedPubMedCentralCrossRefGoogle Scholar
  28. Radulescu RT. From the RB tumor suppressor to MCR peptides. Protein Pept Lett. 2014;21:589–92.PubMedPubMedCentralCrossRefGoogle Scholar
  29. Radulescu RT. The nucleocrine pathway comes of age. Romanian J Morphol Embryol. 2015;56(2):343–8. PMID: 26193197. https://www.ncbi.nlm.nih.gov/pubmed/26193197?dopt=AbstractPlus
  30. Radulescu RT, Fahraeus R. Targeting the RB pathway for cancer therapy: peptide mimetic foundations and promise. Am J Transl Res. 2010;2:209.PubMedPubMedCentralGoogle Scholar
  31. Radulescu RT, Jaques G. Selective inhibition of human lung cancer cell growth by peptides derived from retinoblastoma protein. Biochem Biophys Res Commun. 2000;267:71–6.PubMedPubMedCentralCrossRefGoogle Scholar
  32. Radulescu RT, Jaques G. Potent in vivo antineoplastic activity of MCR peptides MCR-4 and MCR-14 against chemotherapy-resistant human small cell lung cancer. Drugs Exp Clin Res. 2003;29:69–74.PubMedPubMedCentralGoogle Scholar
  33. Radulescu RT, Doklea E, Kehe K, Mückter H. Nuclear colocalization and complex formation of insulin with retinoblastoma protein in HepG2 human hepatoma cells. J Endocrinol. 2000;166:R1–4.PubMedPubMedCentralCrossRefGoogle Scholar
  34. Sarbu SM, Kane TC, Kinkle BK. A chemoautotrophically based cave ecosystem. Science. 1996;272:1953–5.PubMedPubMedCentralCrossRefGoogle Scholar
  35. Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE, Herman JG. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res. 1997;57:3126–30.PubMedPubMedCentralGoogle Scholar
  36. Sherr CJ. Cancer cell cycles. Science. 1996;274:1672–7.CrossRefPubMedGoogle Scholar
  37. Slack RS, El-Bizri H, Wong J, Belliveau DJ, Miller FD. A critical temporal requirement for the retinoblastoma protein family during neuronal determination. J Cell Biol. 1998;140:1497–509.PubMedPubMedCentralCrossRefGoogle Scholar
  38. Takemura M. Evolutionary history of the retinoblastoma gene from archaea to eukarya. Biosystems. 2005;82:266–72.PubMedPubMedCentralCrossRefGoogle Scholar
  39. Thomas L. The youngest science – notes of a medicine-watcher. New York: Bantam Books; 1983. p. 202–3.Google Scholar
  40. Wang NP, Chen PL, Huang S, Donoso LA, Lee WH, Lee EY. DNA-binding activity of retinoblastoma protein is intrinsic to its carboxyl-terminal region. Cell Growth Differ. 1990;1:233–9.PubMedPubMedCentralGoogle Scholar
  41. Wang L, Liu D, Ahmed T, Chung FL, Conaway C, Chiao JW. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int J Oncol. 2004;24:187–92.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Molecular Concepts Research (MCR)MünsterGermany